Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:CTIC
Date3/1997
Raised
Post IPO Valuation

General Information

Websitecelltherapeutics.com
CategoryBioTech
Phone206-282-7100
Employees
Founded1991

Offices

Seattle, USA
501 Elliott Ave. W. #400
Seattle, WA, 98119
USA

People

Founder, President and Chief Executive Officer, Board of Directors
Chairman & Scientific Advisory Board
SVP, Clinical Development and Regulatory Affairs
SVP, Corporate Communications and Investor Relations
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Show All People

Funding

TOTAL $80.1M
FUNDING TOTAL $80.1M
Venture Round, 8/2009
$30M
Venture Round, 5/2010
$21M
Venture Round, 8/2010
$4.06M
Venture Round, 1/2011
$25M
DEBT TOTAL $5M
Debt, 12/2013
Hercules Technology Growth Capital
$5M

Tags

Cell Therapeutics

Cell Therapeutics, Inc., a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Its development portfolio includes Pixantrone, a phase III trial product, for non-Hodgkin’s lymphoma; Brostallicin, which is in first-line Phase II study for the treatment of sarcoma; and OPAXIO, a chemotherapeutic agent for the potential treatment of non-small cell lung, ovarian, and other cancers. It has collaboration and licensing arrangements with Novartis International Pharmaceutical, Ltd.; and PG-TXL Company, L.P. The company was founded in 1991 and is headquartered in Seattle, Washington.

Recent Milestones

Videos

Screenshots

Cell Therapeutics screenshot
Above: Home Page
Uploaded: 1/16/10

Stock Price

Sources

  1. Cell Therapeutics stock sale raises $30M and eyebrows (fiercebiotech.com) [edit]
  2. Struggling Cell Therapeutics raises $21M in stock sale (fiercebiotech.com) [edit]
  3. SEC (sec.gov) [edit]
  4. Cell Therapeutics raises $25M (fiercebiotech.com) [edit]
  5. Cell Therapeutics gets remaining $5 mln from Hercules Technology loan (pehub.com) [edit]
  6. UPDATED: Cell Therapeutics lands myelofibrosis drug with $30M upfront (fiercebiotech.com) [edit]
    Cell Therapeutics gets $5 million payment from Teva for TRISENOX (news-medical.net) [edit]
Edit This Page
Last Edited 4/1/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy